Related references
Note: Only part of the references are listed.Lysosomal glycosphingolipid catabolism by acid ceramidase: formation of glycosphingoid bases during deficiency of glycosidases
Maria J. Ferraz et al.
FEBS LETTERS (2016)
Mass spectrometric quantification of glucosylsphingosine in plasma and urine of type 1 Gaucher patients using an isotope standard
Mina Mirzaian et al.
BLOOD CELLS MOLECULES AND DISEASES (2015)
Plasma globotriaosylsphingosine in relation to phenotypes of Fabry disease
Bouwien E. Smid et al.
JOURNAL OF MEDICAL GENETICS (2015)
Fabry disease: The α-galactosidase A (GLA) c.427G>A (A143T) mutation, effect of the 5′-10C>T polymorphism
Robert J. Desnick et al.
MOLECULAR GENETICS AND METABOLISM (2015)
The alpha-galactosidase A p.Arg118Cys variant does not cause a Fabry disease phenotype: Data from individual patients and family studies
Susana Ferreira et al.
MOLECULAR GENETICS AND METABOLISM (2015)
Coformulation of a Novel Human α-Galactosidase A With the Pharmacological Chaperone AT1001 Leads to Improved Substrate Reduction in Fabry Mice
Su Xu et al.
MOLECULAR THERAPY (2015)
Thromboembolic events in Fabry disease and the impact of factor V Leiden
Malte Lenders et al.
NEUROLOGY (2015)
Gene Mutations Versus Clinically Relevant Phenotypes Lyso-Gb3 Defines Fabry Disease
Markus Niemann et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2014)
Detecting multiple lysosomal storage diseases by tandem mass spectrometry - A national newborn screening program in Taiwan
Hsuan-Chieh Liao et al.
CLINICA CHIMICA ACTA (2014)
Fabry disease: A new approach for the screening of females in high-risk groups
Gabriela Pasqualim et al.
CLINICAL BIOCHEMISTRY (2014)
Familial globotriaosylceramide-associated cardiomyopathy mimicking Fabry disease
Turid Apelland et al.
HEART (2014)
Uncertain diagnosis of Fabry disease: Consensus recommendation on diagnosis in adults with left ventricular hypertrophy and genetic variants of unknown significance
B. E. Smid et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2014)
A systematic review on screening for Fabry disease: prevalence of individuals with genetic variants of unknown significance
L. van der Tol et al.
JOURNAL OF MEDICAL GENETICS (2014)
Cryptogenic stroke and small fiber neuropathy of unknown etiology in patients with alpha-galactosidase A-10T genotype
Michael Schelleckes et al.
ORPHANET JOURNAL OF RARE DISEASES (2014)
Risk of Death in Heart Disease is Associated With Elevated Urinary Globotriaosylceramide
Raphael Schiffmann et al.
JOURNAL OF THE AMERICAN HEART ASSOCIATION (2014)
Newborn screening for Fabry disease in Japan: prevalence and genotypes of Fabry disease in a pilot study
Takahito Inoue et al.
JOURNAL OF HUMAN GENETICS (2013)
s Multifocal White Matter Lesions Associated with the D313Y Mutation of the α-Galactosidase A Gene
Malte Lenders et al.
PLOS ONE (2013)
Acute Cerebrovascular Disease in the Young The Stroke in Young Fabry Patients Study
Arndt Rolfs et al.
STROKE (2013)
High-throughput screening identified disease-causing mutants and functional variants of α-galactosidase A gene in Japanese male hemodialysis patients
Kent Doi et al.
JOURNAL OF HUMAN GENETICS (2012)
Fabry Disease: Incidence of the Common Later-Onset α-Galactosidase A IVS4+919G→A Mutation in Taiwanese Newborns-Superiority of DNA-Based to Enzyme-Based Newborn Screening for Common Mutations
Yin-Hsiu Chien et al.
MOLECULAR MEDICINE (2012)
Fabry disease: results of the first UK hemodialysis screening study
E. F. Wallin et al.
CLINICAL NEPHROLOGY (2011)
Fabry disease mimicking hypertrophic cardiomyopathy: genetic screening needed for establishing the diagnosis in women
Ole Havndrup et al.
EUROPEAN JOURNAL OF HEART FAILURE (2010)
Mutations of the GLA Gene in Young Patients With Stroke The PORTYSTROKE Study-Screening Genetic Conditions in PORTuguese Young STROKE Patients
Miguel Viana Baptista et al.
STROKE (2010)
High Incidence of the Cardiac Variant of Fabry Disease Revealed by Newborn Screening in the Taiwan Chinese Population
Hsiang-Yu Lin et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2009)
Screening for Fabry disease in patients with chronic kidney disease: Limitations of plasma alpha-galactosidase assay as a screening test
Jason Andrade et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
Synergistic heterozygosity for TGFβ1 SNPs and BMPR2 mutations modulates the age at diagnosis and penetrance of familial pulmonary arterial hypertension
John A. Phillips et al.
GENETICS IN MEDICINE (2008)
Elevated globotriaosylsphingosine is a hallmark of Fabry disease
Johannes M. Aerts et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Prevalence of Fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy
Lorenzo Monserrat et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
Cellular and tissue localization of globotriaosylceramide in Fabry disease
Hasan Askari et al.
VIRCHOWS ARCHIV (2007)
High incidence of later-onset Fabry disease revealed by newborn screening
Marco Spada et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2006)
α-galactosidase a deficiency leads to increased tissue fibrin deposition and thrombosis in mice homozygous for the factor V Leiden mutation
YC Shen et al.
STROKE (2006)
Effect of genetic modifiers on cerebral lesions in Fabry disease
G Altarescu et al.
NEUROLOGY (2005)
Urinary lipid profiling for the identification of Fabry hemizygotes and heterozygotes
M Fuller et al.
CLINICAL CHEMISTRY (2005)
Fabry disease: D313Y is an alpha-galactosidase A sequence variant that causes pseudodeficient activity in plasma
R Froissart et al.
MOLECULAR GENETICS AND METABOLISM (2003)
Fabry disease: Characterization of alpha-galactosidase A double mutations and the D313Y plasma enzyme pseudodeficiency allele
M Yasuda et al.
HUMAN MUTATION (2003)
Prevalence of Anderson-Fabry disease in male patients with late onset hypertrophic cardiomyopathy
B Sachdev et al.
CIRCULATION (2002)
Synergistic heterozygosity: Disease resulting from multiple partial defects in one or more metabolic pathways
J Vockley et al.
MOLECULAR GENETICS AND METABOLISM (2000)
Share Paper
